LivaNova PLC to Post FY2017 Earnings of $3.36 Per Share, Jefferies Group Forecasts (LIVN)
LivaNova PLC (NASDAQ:LIVN) – Analysts at Jefferies Group raised their FY2017 EPS estimates for shares of LivaNova PLC in a research note issued to investors on Thursday. Jefferies Group analyst R. Denhoy now expects that the company will earn $3.36 per share for the year, up from their previous forecast of $3.29. Jefferies Group has a “Buy” rating and a $91.00 price target on the stock. Jefferies Group also issued estimates for LivaNova PLC’s Q4 2017 earnings at $0.71 EPS, Q1 2018 earnings at $0.81 EPS, Q2 2018 earnings at $0.98 EPS, Q3 2018 earnings at $0.91 EPS, Q4 2018 earnings at $1.00 EPS, FY2018 earnings at $3.70 EPS, FY2019 earnings at $4.10 EPS and FY2020 earnings at $4.55 EPS.
LivaNova PLC (NASDAQ:LIVN) last posted its quarterly earnings data on Thursday, November 2nd. The company reported $0.93 earnings per share for the quarter, topping the consensus estimate of $0.76 by $0.17. LivaNova PLC had a net margin of 4.63% and a return on equity of 9.33%. The firm had revenue of $309.70 million during the quarter, compared to analysts’ expectations of $301.22 million. During the same quarter in the previous year, the company posted $0.78 EPS. LivaNova PLC’s revenue was up 4.9% on a year-over-year basis.
Other analysts have also issued research reports about the stock. BTIG Research reaffirmed a “hold” rating on shares of LivaNova PLC in a report on Tuesday. Berenberg Bank reaffirmed a “buy” rating and set a $70.00 target price on shares of LivaNova PLC in a report on Friday, August 11th. Piper Jaffray Companies reaffirmed a “buy” rating and set a $85.00 target price on shares of LivaNova PLC in a report on Friday, November 3rd. Canaccord Genuity reaffirmed a “hold” rating and set a $71.00 target price on shares of LivaNova PLC in a report on Wednesday, September 20th. Finally, BidaskClub lowered shares of LivaNova PLC from a “buy” rating to a “hold” rating in a report on Tuesday, August 1st. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating to the stock. The stock has an average rating of “Hold” and an average price target of $76.00.
Shares of LivaNova PLC (NASDAQ LIVN) opened at $79.83 on Monday. The company has a current ratio of 2.03, a quick ratio of 1.42 and a debt-to-equity ratio of 0.04. LivaNova PLC has a fifty-two week low of $40.83 and a fifty-two week high of $81.85. The company has a market cap of $3,890.19, a price-to-earnings ratio of 23.25, a price-to-earnings-growth ratio of 2.42 and a beta of 0.52.
In other news, Director Daniel Jeffrey Moore sold 1,000 shares of the business’s stock in a transaction on Tuesday, August 15th. The shares were sold at an average price of $60.76, for a total value of $60,760.00. Following the completion of the transaction, the director now owns 58,296 shares of the company’s stock, valued at approximately $3,542,064.96. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders sold a total of 3,000 shares of company stock valued at $203,890 in the last three months. 0.28% of the stock is owned by company insiders.
Several hedge funds have recently made changes to their positions in LIVN. PNC Financial Services Group Inc. grew its holdings in shares of LivaNova PLC by 9.8% in the 2nd quarter. PNC Financial Services Group Inc. now owns 1,707 shares of the company’s stock valued at $105,000 after buying an additional 153 shares during the period. Riverhead Capital Management LLC grew its holdings in shares of LivaNova PLC by 76.3% in the 2nd quarter. Riverhead Capital Management LLC now owns 1,763 shares of the company’s stock valued at $108,000 after buying an additional 763 shares during the period. Exane Derivatives grew its holdings in shares of LivaNova PLC by 814.8% in the 2nd quarter. Exane Derivatives now owns 3,156 shares of the company’s stock valued at $158,000 after buying an additional 2,811 shares during the period. Teacher Retirement System of Texas acquired a new position in shares of LivaNova PLC in the 2nd quarter valued at $204,000. Finally, LS Investment Advisors LLC grew its holdings in shares of LivaNova PLC by 14.5% in the 2nd quarter. LS Investment Advisors LLC now owns 3,449 shares of the company’s stock valued at $211,000 after buying an additional 436 shares during the period. 81.69% of the stock is owned by institutional investors.
LivaNova PLC Company Profile
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.
Receive News & Stock Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related stocks with our FREE daily email newsletter.